Delivery Order SPE2DB22D2206-SPE2DB25FKD44
Award Date 9/28/25
Potential Completion Date 10/20/25
Potential Value $103K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $11,435.46 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Yervoy 50 mg/10 ml vials. This competitively awarded, firm fixed price delivery order is scheduled for completion by August 20, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA....
- The Defense Logistics Agency awarded a $49,957.75 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Yervoy 200 mg/40 mL vials. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 16, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The award represents a child delivery order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $11,435.46 delivery order to AmerisourceBergen Drug Corp for Yervoy 50 mg/10 mL vials. This delivery order, issued on September 4, 2025, represents a competitive, non-set-aside award with firm fixed pricing and an ultimate completion date of September 25, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. Yervoy is an immunotherapy medication used in cancer treatment, reflecting the Defense...
- The Defense Logistics Agency awarded a $17,153.19 delivery order to AmerisourceBergen Drug Corp for Yervoy (ipilimumab) 50 mg/10 mL vials on August 21, 2025, with an ultimate completion date of September 12, 2025. This non-competitive delivery order operates under a firm fixed price structure and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Yervoy is a checkpoint inhibitor immunotherapy commonly used in cancer treatment, reflecting the...
- The Defense Logistics Agency awarded a $25,022.41 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Yervoy 200 mg/40 mL vials. The contract represents a firm fixed-price delivery against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply...
- The Defense Logistics Agency awarded a $37,864.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of YERVOY (ipilimumab) 200 mg/40 mL vials. The contract, awarded on May 12, 2025, with an ultimate completion date of June 3, 2025, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to meet federal pharmaceutical...
- The Defense Logistics Agency awarded a $13,499.88 delivery order to AmerisourceBergen Drug Corp for Yervoy 50 mg/10 ml vials, with a completion date of June 24, 2025. This competitive, firm fixed-price delivery order represents a non-set-aside procurement supporting the federal government's pharmaceutical supply requirements. The contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of YERVOY (ipilimumab) 50 mg/10 mL vials, with a contract ceiling value of $22,870.92. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through competitive procurement. The contract is set to be completed by September 30, 2025, with performance occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $5,717.73, is for the delivery of Yervoy 50 mg/10 ml vials. It is a firm fixed-price delivery order contract that runs through February 5, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of YERVOY 50 MG/10 ML VIAL 10ML, a prescription medication, to support federal healthcare requirements. The contract has a ceiling value of $11,435.46 and a completion date of June 9, 2025. It is a firm-fixed-price delivery order contract with no set-aside designation, indicating open...